众兴菌业股价涨5.2%,宏利基金旗下1只基金位居十大流通股东,持有349.8万股浮盈赚取297.33万元

Group 1 - The core viewpoint of the news is that Zhongxing Mushroom Industry has seen a stock price increase of 5.2%, reaching 17.21 yuan per share, with a trading volume of 110 million yuan and a turnover rate of 1.67%, resulting in a total market capitalization of 6.768 billion yuan [1] - Zhongxing Mushroom Industry, established on November 18, 2005, and listed on June 26, 2015, is primarily engaged in the research, industrial cultivation, and sales of edible mushrooms [1] - The main revenue composition of Zhongxing Mushroom Industry includes: 63.04% from Agaricus bisporus, 35.32% from Enoki mushrooms, 0.89% from Cordyceps sinensis, 0.53% from ecological breeding of Cordyceps, and 0.22% from other sources [1] Group 2 - Hongli Fund's Hongli Consumer Dividend Index A (008928) is among the top ten circulating shareholders of Zhongxing Mushroom Industry, having increased its holdings by 363,100 shares to a total of 3.498 million shares, representing 0.9% of the circulating shares [2] - The fund has a current scale of 720 million yuan, with a year-to-date loss of 0.21% and a one-year return of 8.18%, ranking 3738 out of 4297 in its category [2] - The fund manager, Li Tingting, has been in the position for 4 years and 59 days, with the best fund return during her tenure being 43.8% and the worst being -35.89% [2] Group 3 - In the fourth quarter, Hongli Consumer Dividend Index A (008928) reduced its holdings in Zhongxing Mushroom Industry by 126,900 shares, now holding 2.229 million shares, which accounts for 2.84% of the fund's net value, making it the fifth-largest holding [3] - The fund has achieved a floating profit of approximately 1.8947 million yuan from its current holdings in Zhongxing Mushroom Industry [3]

Zhongxing BioTech-众兴菌业股价涨5.2%,宏利基金旗下1只基金位居十大流通股东,持有349.8万股浮盈赚取297.33万元 - Reportify